Novartis | LinkedIn (original) (raw)
Info
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
Branche
Arzneimittelherstellung
Größe
10.001+ Beschäftigte
Hauptsitz
Basel, Baselstadt
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Spezialgebiete
Cardiovascular, Immunology, Neuroscience, Solid Tumors, Hematology, Chemistry, xRNA, Radioligand und Gene and cell therapy
Orte
- Primär
Novartis Campus
Basel, Baselstadt 4002, CH
Wegbeschreibung - One Health Plaza
East Hanover, NJ 07936, US
Wegbeschreibung - Calle 93B S-31
Bogota, Bogota, D.C. 110541, CO
Wegbeschreibung - Merrion Road
Dublin, County Dublin, IE
Wegbeschreibung - Na Pankraci 1724/129
Prague, Prague 140 00, CZ
Wegbeschreibung - Via Espana
Panama City, Panama, PA
Wegbeschreibung - Edvard Thomsens Vej 14
Copenhagen, Capital Region 2300, DK
Wegbeschreibung - Tirana, AL, AL
Wegbeschreibung - Buenos Aires, AR
Wegbeschreibung - Macquairie Park, NSW, AU
Wegbeschreibung - Wien, AT
Wegbeschreibung - Kundl, Tirol, AT
Wegbeschreibung - Baku, AZ
Wegbeschreibung - Amsterdam, NL
Wegbeschreibung - Auckland, NZ
Wegbeschreibung - Ikeja, Lagos, NG
Wegbeschreibung - Skopje, MK
Wegbeschreibung - Oslo, NO
Wegbeschreibung - Muscat, OM
Wegbeschreibung - Karachi, PK
Wegbeschreibung - Ciudad de Panamá, PA
Wegbeschreibung - Ciudad de Panamá, PA
Wegbeschreibung - Lima, PE
Wegbeschreibung - Makati City, PH
Wegbeschreibung - Warsaw, PL
Wegbeschreibung - Porto Salvo, PT
Wegbeschreibung - Cataño, PR
Wegbeschreibung - Dhaka, BD
Wegbeschreibung - St. Michael, BB
Wegbeschreibung - Minsk, BY
Wegbeschreibung - Brussels, BE
Wegbeschreibung - Sarajevo, BA
Wegbeschreibung - Sao Paulo, BR
Wegbeschreibung - Sofia, BG
Wegbeschreibung - Douala, CM
Wegbeschreibung - Quebec, CA
Wegbeschreibung - Santiago de Chile, CL
Wegbeschreibung - Beijing, CN
Wegbeschreibung - Shanghai, CN
Wegbeschreibung - Santafe de Bogota, CO
Wegbeschreibung - San Jose, CR
Wegbeschreibung - Abidjan, CI
Wegbeschreibung - Zagreb, HR
Wegbeschreibung - Wilemstad, CW
Wegbeschreibung - Doha, QA
Wegbeschreibung - Bucharest, RO
Wegbeschreibung - Ekaterinburg, RU
Wegbeschreibung - Kazan, RU
Wegbeschreibung - Leshkovo Village, Moscow, RU
Wegbeschreibung - Moscow, RU
Wegbeschreibung - Novosibirsk, RU
Wegbeschreibung - Rostov-on-Don , RU
Wegbeschreibung - St. Petersburg, RU
Wegbeschreibung - Dammam, SA
Wegbeschreibung - Jeddah, SA
Wegbeschreibung - Riyadh, SA
Wegbeschreibung - Dakar, SN
Wegbeschreibung - Novi Beograd, RS
Wegbeschreibung - Singapore Country, SG
Wegbeschreibung - Bratislava, SK
Wegbeschreibung - Ljubljana, SI
Wegbeschreibung - Kempton Park, Gauteng, ZA
Wegbeschreibung - Seoul, KR
Wegbeschreibung - Barcelona, ES
Wegbeschreibung - Sardón de Duero / Valladolid, ES
Wegbeschreibung - Colombo, LK
Wegbeschreibung - Montevideo, UY
Wegbeschreibung - Tashkent, UZ
Wegbeschreibung - Caracas, VE
Wegbeschreibung - Ho Chi Minh City, VN
Wegbeschreibung - Lusaka, ZM
Wegbeschreibung
Beschäftigte von Novartis
Updates
-
3.981.699 Follower:innen
5 Tage
Novartis is on a mission to break down barriers to cardiovascular, renal, and metabolic (CRM) treatments through empathy, access, and innovation. In a recent interview, Dianne Auclair Rocha, SVP and TA Head, Cardiovascular, Renal and Metabolic in the US and Vasilisa Sazonov, Therapy Area Head Cardiovascular, Renal, Metabolic internationally talked about their focus on prevention through education, early screening efforts, and partnerships to reduce access barriers for patients. The leaders emphasized the importance of understanding patient needs and fostering a patient-centered approach, as well as the role of personalized medicine and digital health in the future. Hear more about these leaders' perspectives on the importance of tackling the challenges in the cardiovascular, renal and metabolic space in the article: https://lnkd.in/gTaQHTEJ
Live. Magazine live.novartis.com -
3.981.699 Follower:innen
2 Wochen
We’re thrilled to announce that Novartis, a proudly Swiss company, is an Official Partner of the Eurovision Song Contest 2025, hosted in our headquarters city of #Basel, #Switzerland. Like Novartis, the Eurovision Song Contest was founded in Switzerland, and we’re delighted to offer our support to this legendary contest and our home country. For ten unforgettable days, Basel will transform into a global hub of creativity and community, bringing together millions of viewers from across the world and thousands of visitors to Basel. With 78,000 employees from over 100 countries, at Novartis, we believe in the power of collective creativity and international collaboration — values we share with Eurovision. So, here’s to seizing the moment and meeting at the intersection of science and creativity! Stay tuned for more news on our involvement. Novartis, where health takes center stage. #EurovisionBasel #novartislife #HealthCentreStage #ESC2025 #Eurovision #Eurovision2025 European Broadcasting Union (EBU) SRG SSR -
3.981.699 Follower:innen
2 Wochen Bearbeitet
This FDA approval for adults with newly diagnosed chronic myeloid leukemia (#CML) is vital for the clinical and patient communities. As a part of our 20+-year commitment to innovation and support in CML, we continue to work alongside the clinical and patient communities.#ReimaginingMedicine
99.640 Follower:innen
2 Wochen
We are proud to announce the FDA approval for adults with newly diagnosed Ph+ chronic myeloid leukemia (#CML) in chronic phase. About 10,000 people each year are diagnosed with chronic myeloid leukemia in the US. With this approval, up to 4 times the number of currently eligible patients will have the opportunity to explore a new treatment.#NovartisNews #ReimaginingMedicine -
3.981.699 Follower:innen
2 Wochen
Our Q3 performance reflects the strong operational performance and key pipeline milestones this quarter. With continued strong business momentum in our business and pipeline, we were able to once again upgrade our full-year guidance. We remain highly confident in our mid-term outlook. https://lnkd.in/gT6qWxsx #NVSQ324 - Novartis hat dies direkt geteilt
Executive Vice President, Chief Commercial Officer, Novartis US | Corporate Board Director
1 Monat
At Novartis, we have the scale, expertise and capabilities to help turn molecules into medicines into patient outcomes. In addition to research from our own labs, we are always looking for opportunities to join forces with biotech companies to ensure that the most promising innovation has the best chance of reaching patients. I recently joined Michelle Benz for a fireside chat at the Fierce Biotech Summit where we discussed our creative approach to partnerships which has led to successful collaborations to advance patient care. We talked a lot about making decisions with our heads (understanding where mutual value is created), hearts (doing what’s right for patients) and hands (doing our best to get cutting-edge science to market). When the head, heart and hands are there, everyone wins! Get in touch to reimagine medicine, together: https://lnkd.in/eJgaDR8W -
3.981.699 Follower:innen
4 Wochen
As #BreastCancerAwarenessMonth continues, we’re spotlighting EUROPA DONNA - The European Breast Cancer Coalition Breast Health Day campaign encouraging people of all ages to understand the importance of breast cancer prevention. We are honored to join the community in driving these important conversations and continue raising awareness of breast cancer and its impact.#BCAM
2.590 Follower:innen
1 Monat Bearbeitet
🌸 It's Breast Health Day! 🌸 On this 15th of October, Europa Donna encourages women of all ages to take steps towards breast cancer prevention and understand the importance of early detection ✨ Here are some tips to keep your breast health in check: 🍎 Eat a balanced diet rich in fruits and vegetables. 💃 Stay active – regular exercise supports a healthy lifestyle. 🤸♀️ Limit alcohol and avoid smoking. 🔍 Don’t forget regular check-ups – early detection saves lives. Start a healthier life TODAY. Make every choice count 💗 🔗 https://bit.ly/4dIGKzTIllustrations by Libby VanderPloegAnimation by Gary Dumbill #BreastHealthDay #EuropaDonna #BreastCancerAwareness #Prevention #HealthyLiving #BHD -
3.981.699 Follower:innen
1 Monat
Novartis announces positive CHMP opinion for adults diagnosed with stage II or III HR+/HER2- #EarlyBreastCancer, who face high risk of recurrence, including those with node-negative disease. People diagnosed with this type of early breast cancer face the reality that their cancer could come back in the long term, often as incurable, metastatic disease. People with breast cancer deserve more treatment options that might have a tangible impact on their lives and make a meaningful difference in their journey. This milestone means adults living with stage II or III HR+/HER2- early breast cancer in Europe are now one step closer to having a new option that could help them take back control and reduce their risk of recurrence.#ReimaginingMedicine -
3.981.699 Follower:innen
1 Monat
Every year, over 2 million people are diagnosed with #BreastCancer globally. This #BreastCancerAwarenessMonth, we are excited to spotlight the incredible work of Rethink Breast Cancer to empower and support those affected by this disease. We are proud to stand alongside the community and support their efforts in raising awareness of breast cancer and its impact. Join the conversation and learn more about breast cancer. Every share, every voice, and every action make a difference.#BCAM
1.750 Follower:innen
1 Monat
YOU DESERVE TO BE COUNTED. #MAKEMECOUNTBreast cancer awareness month is here. Every October, the media cycle and public focus shifts ever so briefly to our cause and that can bring on a mix of emotions for our community, our team sure feels it, myself, too. “Yay” that we are being seen and talked about. But “ouch” when the story is full of gaps. And that’s a big part of why we launched #MakeMeCount today. That juxtaposition between the general public’s perceptions of breast cancer and the reality of the community’s experiences can be quite jarring and exposes the gaps. The dominant breast cancer story has a lot of gaps because our cancer data has gaps. It’s incomplete. It’s reported on at too high a level. We don’t know how many Black women are diagnosed in Canada. We don’t know how Indigenous communities are impacted. We don’t have data on outcomes for sexual and gender diverse groups. We don’t know how disabilities or income play a role in someone’s care. Vesna is someone who had a metastatic recurrence and she, too, is not counted. Only her first early-stage breast cancer diagnosis is captured in the stats. Her past 7.5 years of MBC treatment aren’t captured. Watch her video below. We can guess at who is having worse outcomes and why, but guessing isn’t good enough. Rethink wants more human dimensions to be counted in the data. Because you count when you’re counted. With #MakeMeCount, we are calling out the need for improved reporting on metastatic recurrence data, race-based data, and social determinants of health data within the breast cancer community. Head to the 🔗 below to sign our petition today and watch the videos of our “stat stars” to learn more about the real people who are impacted by these gaps. For more on why this campaign matters, our history of working on these issues and what actions we’re taking, MJ, Rethink’s Founder + Executive Director has written a blog, which you can read via the 🔗 below too. 👉 https://lnkd.in/eQSPXhK3Thank you for your support in using your voice to help close these gaps. 💗 #MakeMeCount🏷️ #breastcancer #breastcancercommunity #metastaticbreastcancer #mbc #cancerdata #breastcancerawarenessmonth #breastcancercharity #cancercharity #canceradvocate #canceradvocacy #breastcanceradvocacy #rethinkbreastcancer
Einfach anmelden, damit Sie nichts verpassen.
Verbundene Seiten
- Novartis India Arzneimittelherstellung Mumbai, Maharashtra
- Novartis Science Arzneimittelherstellung Cambridge, MA
- Novartis Brasil Arzneimittelherstellung São Paulo, São Paulo
- Novartis Italia Arzneimittelherstellung Milan, Lombardy
- Novartis US Arzneimittelherstellung East Hanover, New Jersey
- Novartis Gene Therapies Biotechnologieforschung Bannockburn, llinois
- Novartis México Arzneimittelherstellung Ciudad de Mexico, Tizapán San Ángel
- Novartis España Arzneimittelherstellung Barcelona, Cataluña, España
- Novartis Portugal Arzneimittelherstellung Oeiras, Porto Salvo
- Novartis Colombia Arzneimittelherstellung
- Novartis Deutschland Arzneimittelherstellung Nürnberg, Bayern
- Novartis, Australia & New Zealand Arzneimittelherstellung Macquarie Park, NSW
- Novartis Canada Arzneimittelherstellung Montreal, Quebec
- Novartis Gulf | نوفارتس الخليج Arzneimittelherstellung
- Novartis in Slovenia Arzneimittelherstellung Ljubljana, Ljubljana
- Novartis Argentina Arzneimittelherstellung
- Novartis US Medical Arzneimittelherstellung
- Novartis Ireland Arzneimittelherstellung Dublin, Dublin
- Novartis Singapore Arzneimittelherstellung
- Novartis România Arzneimittelherstellung Sector 2, Bucharest
- Novartis Czech Republic Arzneimittelherstellung Praha 4, Hlavní město Praha
- Novartis Nederland Arzneimittelherstellung Amsterdam, North Holland
- Novartis Norge Arzneimittelherstellung Nydalen, Oslo
- Novartis Belux Arzneimittelherstellung Vilvoorde, Flemish Region
- Novartis Danmark Arzneimittelherstellung
- Novartis Sverige Arzneimittelherstellung Kista, Stockholm
- Novartis Slovakia Arzneimittelherstellung Bratislava, Slovak Republic
- Novartis Finland Arzneimittelherstellung
- Novartis Magyarország Arzneimittelherstellung
- Novartis Serbia Arzneimittelherstellung
- Novartis Israel Arzneimittelherstellung
- Novartis Hong Kong Arzneimittelherstellung
- Novartis Medical Arzneimittelherstellung
Ähnliche Seiten
Aktien
NVS
18. November 2024
NYSE
Verzögerung von 20 Minuten
Aktiv
102,5
Niedrig
102,48
Hoch
103,42
Daten von Refinitiv